A US supreme court hearing that held the potential to reshape abortion access and the US Food and Drug Administration’s authority did not go well for anti-abortion doctors behind the case, legal experts said on Tuesday.
The consensus is a positive sign for abortion rights advocates, who feared the case would curtail access to medication abortions, which now account for the majority of all abortions nationally.
